Mark C
Schneyer
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Acadia Pharmaceuticals Inc (ACAD) | Schneyer | $546,428 | $3,119,408 |
| 2024 | Acadia Pharmaceuticals Inc (ACAD) | Schneyer | $518,470 | $2,517,513 |
| 2023 | Acadia Pharmaceuticals Inc (ACAD) | Schneyer | $484,842 | $2,591,204 |
| 2022 | Acadia Pharmaceuticals Inc (ACAD) | Schneyer | $467,283 | $2,353,204 |
| 2021 | Acadia Pharmaceuticals Inc (ACAD) | Schneyer | $398,183 | $3,182,819 |
Earnings-call appearances
No earnings-call appearances recorded yet.